2565 — Pegbio Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$12.35bn
- HK$12.46bn
Annual cashflow statement for Pegbio Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Net Income/Starting Line | -279 | -283 |
| Depreciation | ||
| Amortisation | ||
| Non-Cash Items | 29.8 | 142 |
| Unusual Items | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | 12.4 | -44.6 |
| Change in Other Assets | ||
| Change in Accrued Expenses | ||
| Change in Payable / Accrued Expenses | ||
| Change in Other Liabilities | ||
| Other Operating Cash Flow | ||
| Cash from Operating Activities | -233 | -183 |
| Capital Expenditures | -0.617 | -1.08 |
| Purchase of Fixed Assets | ||
| Purchase / Acquisition of Intangibles | ||
| Other Investing Cash Flow Items | 102 | 115 |
| Sale/Maturity of Investment | ||
| Purchase of Investments | ||
| Sale of Intangible Assets | ||
| Cash from Investing Activities | 102 | 114 |
| Financing Cash Flow Items | 132 | -3.93 |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | 149 | 20.3 |
| Foreign Exchange Effects | ||
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | 16.9 | -48.8 |